| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Surgery, The University of Texas Medical Branch, Galveston, Texas 77555 [J. I., C. M. T., Jr., R. J. B., J. C. T.] and Centre CNRS-INSERM de Pharmacologie-Endocrinologie, Rue de la Cardonille, 34094 Montepellier, Cedex 5, France [J. M., M. R.]
Gastrin is a trophic factor for some human colon cancer cells. However, the signal-transduction pathways by which gastrin regulates growth are still unknown. We examined the effect of synthetic human gastrin-17 (G-17) on signal-transduction pathways and cell growth using 4 different human colon cancer cell lines (LoVo, COLO 320, HT-29, and HCT116). G-17 stimulated the production of cyclic AMP in LoVo, COLO 320, and HCT116 cells, while G-17 stimulated phosphatidylinositol hydrolysis and mobilization of intracellular calcium in HT-29 cells. The growth-regulatory effect of G-17 on these colon cancer cells (stimulatory on LoVo, COLO 320, and HT-29 cells; inhibitory on HCT116 cells) was well correlated with the effect of G-17 on the signal-transduction pathway in each cell line. We further examined the effect of a selective cholecystokinin-B type receptor antagonist, JMV 320, on G-17-induced signal-transduction pathways and G-17-regulated growth. In each cell line, the effect of JMV 320 on G-17-induced signal-transduction pathways was well correlated with that on G-17-regulated growth. G-17 appears to regulate, at least to some extent, growth of human colon cancer cells through gastrin receptor-linked signal-transduction pathways that are cell-specific.
1 Supported by grants from the NIH (5R37 DK 15241 and P01 DK 35608), American Cancer Society (CB-571), Walls Medical Research Foundation, and the John Sealy Memorial Endowment Fund.
2 To whom requests for reprints should be addressed, at Department of Surgery, Route E-33, 6.136 Old John Sealy, The University of Texas Medical Branch, Galveston, TX 77555-0533.
Received 8/27/93. Accepted 2/18/94.
This article has been cited by other articles:
![]() |
R. P. Thomas, M. R. Hellmich, C. M. Townsend Jr., and B. M. Evers Role of Gastrointestinal Hormones in the Proliferation of Normal and Neoplastic Tissues Endocr. Rev., October 1, 2003; 24(5): 571 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Thommesen, E. Hofsli, R. H. Paulssen, M. W. Anthonsen, and A. Lagreid Molecular mechanisms involved in gastrin-mediated regulation of cAMP-responsive promoter elements Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1316 - E1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hata, Y. Takebayashi, S. Akiba, R. Fujiwaki, K. Iida, K. Nakayama, S. Nakayama, M. Fukumoto, and K. Miyazaki Expression of the adrenomedullin gene in epithelial ovarian cancer Mol. Hum. Reprod., October 1, 2000; 6(10): 867 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Thommesen, K. Norsett, A. K. Sandvik, E. Hofsli, and A. Lagreid Regulation of Inducible cAMP Early Repressor Expression by Gastrin and Cholecystokinin in the Pancreatic Cell Line AR42J J. Biol. Chem., February 11, 2000; 275(6): 4244 - 4250. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Stepan, C. J. Dickinson, J. del Valle, M. Matsushima, and A. Todisco Cell type-specific requirement of the MAPK pathway for the growth factor action of gastrin Am J Physiol Gastrointest Liver Physiol, June 1, 1999; 276(6): G1363 - G1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. MICHISHITA, T. MINEGISHI, K. ABE, K. KANGAWA, M. KOJIMA, and Y. IBUKI Expression of Adrenomedullin in the Endometrium of the Human Uterus Obstet. Gynecol., January 1, 1999; 93(1): 66 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Isumi, N. Minamino, T. Katafuchi, M. Yoshioka, T. Tsuji, K. Kangawa, and H. Matsuo Adrenomedullin Production in Fibroblasts: Its Possible Function as a Growth Regulator of Swiss 3T3 Cells Endocrinology, May 1, 1998; 139(5): 2552 - 2563. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Detjen, D. Yule, M.-J. Tseng, J. A. Williams, and C. D. Logsdon CCK-B receptors produce similar signals but have opposite growth effects in CHO and Swiss 3T3 cells Am J Physiol Cell Physiol, November 1, 1997; 273(5): C1449 - C1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Montuenga, A. Martinez, M. J. Miller, E. J. Unsworth, and F. Cuttitta Expression of Adrenomedullin and Its Receptor during Embryogenesis Suggests Autocrine or Paracrine Modes of Action Endocrinology, January 1, 1997; 138(1): 440 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Miller, A. Martinez, E. J. Unsworth, C. J. Thiele, T. W. Moody, T. Elsasser, and F. Cuttitta Adrenomedullin Expression in Human Tumor Cell Lines. ITS POTENTIAL ROLE AS AN AUTOCRINE GROWTH FACTOR J. Biol. Chem., September 20, 1996; 271(38): 23345 - 23351. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Singh, A. Owlia, R. Espeijo, and B. Dai Novel Gastrin Receptors Mediate Mitogenic Effects of Gastrin and Processing Intermediates of Gastrin on Swiss 3T3 Fibroblasts J. Biol. Chem., April 14, 1995; 270(15): 8429 - 8438. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |